Sugar Editorial Picks
Sep 24, 2008 -
Feeling stressed? It could be a sign of the times or it could also be a sign of where you live. Some cities are more stressful than others, and Forbes has outlined the top 10 most stressful cities in the US.
- 23 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- The Body's Response
- Complications
- Conditions with Similar Sym...
- Treatment
- Risk Factors
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
- Some people are pre-programmed for a heightened response to stress by conditions in the womb. Pregnant women under stress who eat a diet high in protein and low in carbohydrates have babies with higher cortisol levels. Later on, these levels increase in response to stress.
- The impact of stress on the heart and circulation system is becoming more clear.
- 0 Comments
Sep 08, 2009 -
Your city's plummeting property values, high unemployment rate, extreme weather, or chronic traffic could potentially stress you out. Some metropolises have a perfect storm of frustrating factors that landed them on Forbes's list of America's Most Stressful Cities.
Coming in at number one is Chicago, thanks to the city's poor air quality, 11 percent unemployment rate, and falling home prices.
- 24 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, duloxetine (Cymbalta) was approved for treatment of generalized anxiety disorder. Duloxetine is a dual inhibitor antidepressant.
Anxiety Disorders Under-Recognized and Under-Treated
About 41% of patients with an anxiety disorder do not receive any treatment, indicates a 2007 study in the Annals of Internal Medicine.
- 1 Comment
Jul 30, 2009 -
- 18 foods to fuel a pregnant body
- Agents of change: Obama awards medals of freedom
- Trend Alert: fuss-free on the red carpet
- Guess the celeb by her sassy shoe!
- Do you prefer Katherine Heigl on TV or in movies?
- Five fashion forward laptop bags and sleeves
- Do you ever steal from the office fridge?
- Love your city? Say it with art
- An alarm clock that motivates you to work out
- All aboard! 8 things before boarding with Fido
- Americans' love lives most stressed by recession
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Prognosis
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Health care providers need to carefully observe patients for 2 hours after they receive an omalizumab injection. However, because an allergic reaction can occur up to 24 hours after the injection, patients need to know the signs and symptoms of anaphylaxis and how to self-administer emergency treatment.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Prevention
- Treatment
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Asthma is a chronic disease that involves inflammation of the lungs. Airways swell and restrict airflow in and out of the lungs, making it hard to breathe. The word asthma comes from the Greek word for "panting."
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Biologic Drugs
- In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
- As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Considerations
- Male Contraception
- Surgery
- Complications
- Unexpected Pregnancy
- Long-Term Complications
- Reversal Surgery
- Assisted Reproductive Techn...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Search Continues for the "Male Pill"
Research is progressing on a male contraceptive, but there have also been setbacks. The drug miglustat (Zavesca), which is used to treat a rare condition called Gaucher's disease, had shown success in animal studies but failed to work in a clinical trial, according to results published in 2007 in Human Reproduction. Researchers are now investigating an experimental drug, Adjudin (AF-2364), which disrupts sperm production.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Vaccinations
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
West Nile Virus
In 2007, 3,510 cases of West Nile virus were reported to the U.S. Centers for Disease Control. States with the highest number of reported cases included Colorado, California, and North Dakota.
- 0 Comments